Nicardipine Hydrochloride Tillomed Laboratories

Nicardipine Hydrochloride, the active ingredient in Nicardipine Hydrochloride Tillomed Laboratories, is a calcium channel blocker presented as an oral formulation for oral use. It is employed to manage hypertension and angina pectoris in adult patients, helping to lower blood pressure and relieve chest pain by relaxing arterial smooth muscle.

GNH USA supplies Nicardipine Hydrochloride Tillomed Laboratories as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for global distribution.

Nicardipine Hydrochloride is a calcium channel blocker used to treat conditions involving elevated blood pressure and cardiac workload.

- Hypertension: reduces systemic vascular resistance and lowers arterial blood pressure. - Angina pectoris: improves coronary blood flow and diminishes frequency of chest pain episodes. - Stable coronary artery disease: helps control myocardial oxygen demand and may reduce ischemic symptoms.

Common Side Effects: - Headache: mild to moderate pain often occurring after the first dose. - Flushing: transient warmth and redness of the skin. - Peripheral edema: swelling of the ankles or lower legs. - Dizziness: sensation of light‑headedness, especially when standing quickly.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure that may cause fainting. - Myocardial infarction: rare occurrence of heart attack. - Allergic reaction: rash, itching, or swelling, potentially progressing to angioedema. - Hepatic dysfunction: abnormal liver enzyme elevations. - Cardiac conduction abnormalities: bradyarrhythmias or heart block.

Before initiating therapy, clinicians should consider the following precautions: - Monitor blood pressure regularly: adjust dose based on response. - Assess hepatic function: use with caution in patients with liver impairment. - Avoid abrupt discontinuation: taper to prevent rebound hypertension. - Evaluate for heart failure: monitor for signs of fluid overload. - Use cautiously in elderly patients: increased sensitivity to hypotensive effects. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Nicardipine may interact with several drug classes.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): may increase nicardipine plasma levels. - Concurrent use with other potent antihypertensives (e.g., ACE inhibitors, other calcium channel blockers): risk of additive hypotension. - Grapefruit juice: can elevate systemic exposure and precipitate adverse effects.

Moderate Interactions (Monitor Closely):\n- CYP3A4 inducers (e.g., rifampin, carbamazepine): may reduce therapeutic effect. - Non‑dihydropyridine calcium channel blockers (e.g., verapamil, diltiazem): may increase risk of bradycardia. - Beta‑blockers: combined use may lead to excessive cardiac depression; monitor heart rate and blood pressure.